Effects of glucagon-like peptide-1 receptor agonists on incident gynecologic cancer outcomes in endometriosis patients compared to metformin: A real-world multicenter retrospective cohort study across the United States

Tina Yi Jin Hsieh, Ting‐Tai Yen
In: Gynecologic Oncology · 2025 · vol. 200 , pp. 178 · doi:10.1016/j.ygyno.2025.04.222 · W4414649322
article OA: closed CC0
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex
⚙ AI-generated summary by qwen3.7-flash, 2026-08-27 ⓘ

This retrospective cohort study compared incident gynecologic cancer outcomes in endometriosis patients treated with glucagon-like peptide-1 receptor agonists versus those treated with metformin across multiple US centers.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
unpaywall
last seen: 2026-10-01T06:38:16.588661+00:00
License: CC0 · commercial use OK